Mustang Bio (MBIO) Secures $9.28M Grant to Fund Ongoing Phase 1 Clinical Trial of MB-103 (HER2-Specific CAR T Cells)
Tweet Send to a Friend
Mustang Bio, Inc. (NASDAQ: MBIO) today announced that City of Hope has received a $9.28 million grant from the California ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
